ATE521636T1 - Wachstumsfaktorkomplexe und modulation von zellenmigration und -wachstum - Google Patents

Wachstumsfaktorkomplexe und modulation von zellenmigration und -wachstum

Info

Publication number
ATE521636T1
ATE521636T1 AT04708282T AT04708282T ATE521636T1 AT E521636 T1 ATE521636 T1 AT E521636T1 AT 04708282 T AT04708282 T AT 04708282T AT 04708282 T AT04708282 T AT 04708282T AT E521636 T1 ATE521636 T1 AT E521636T1
Authority
AT
Austria
Prior art keywords
protein complexes
cell migration
growth
growth factor
vitronectin
Prior art date
Application number
AT04708282T
Other languages
English (en)
Inventor
Zee Upton
Christopher Towne
Original Assignee
Univ Queensland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Queensland filed Critical Univ Queensland
Application granted granted Critical
Publication of ATE521636T1 publication Critical patent/ATE521636T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/61—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/65—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/50—Fusion polypeptide containing protease site

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Reproductive Health (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Materials For Medical Uses (AREA)
AT04708282T 2003-02-05 2004-02-05 Wachstumsfaktorkomplexe und modulation von zellenmigration und -wachstum ATE521636T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2003900481A AU2003900481A0 (en) 2003-02-05 2003-02-05 Synthetic modulators of cell migration and growth
PCT/AU2004/000117 WO2004069871A1 (en) 2003-02-05 2004-02-05 Growth factor complexes and modulation of cell migration and growth

Publications (1)

Publication Number Publication Date
ATE521636T1 true ATE521636T1 (de) 2011-09-15

Family

ID=30005181

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04708282T ATE521636T1 (de) 2003-02-05 2004-02-05 Wachstumsfaktorkomplexe und modulation von zellenmigration und -wachstum

Country Status (14)

Country Link
US (1) US7659367B2 (de)
EP (3) EP1594895B1 (de)
JP (2) JP4717799B2 (de)
KR (2) KR101179678B1 (de)
CN (1) CN1774448B (de)
AT (1) ATE521636T1 (de)
AU (1) AU2003900481A0 (de)
CA (1) CA2515335C (de)
DK (1) DK1594895T3 (de)
ES (1) ES2372388T3 (de)
HK (1) HK1091216A1 (de)
NZ (1) NZ541738A (de)
WO (1) WO2004069871A1 (de)
ZA (1) ZA200506991B (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8871709B2 (en) * 2003-02-05 2014-10-28 Queensland University of Technolgy Synthetic chimeric proteins comprising epidermal growth factor and vitronectin
AU2003903896A0 (en) * 2003-07-28 2003-08-07 Queensland University Of Technology Skin regeneration system
US20070128685A1 (en) * 2005-07-01 2007-06-07 Rodolfo Faudoa Methods and compositions for cell culture
US20070004036A1 (en) * 2005-07-01 2007-01-04 Rodolfo Faudoa Methods and compositions for keratinocyte culture
US20070003541A1 (en) * 2005-07-01 2007-01-04 Rodolfo Faudoa Methods and compositions for therapeutics
US20070004037A1 (en) * 2005-07-01 2007-01-04 Rodolfo Faudoa Methods and compositions for culturing keratinocytes
WO2007012144A1 (en) * 2005-07-29 2007-02-01 Australian Stem Cell Centre Limited Compositions and methods for growth of pluripotent cells
US8529819B2 (en) * 2007-03-06 2013-09-10 Covidien Lp Wound closure material
US20100076489A1 (en) * 2007-03-06 2010-03-25 Joshua Stopek Wound closure material
WO2010105302A1 (en) 2009-03-19 2010-09-23 Queensland University Of Technology Targets for growth factor signalling and methods of therapy
NZ600454A (en) * 2009-11-30 2014-10-31 Univ Queensland Fibronectin: growth factor chimeras
US9133266B2 (en) * 2011-05-06 2015-09-15 Wisconsin Alumni Research Foundation Vitronectin-derived cell culture substrate and uses thereof
WO2013076580A2 (en) * 2011-11-23 2013-05-30 Bioven 3 Limited Recombinant proteins and their therapeutic uses
MX2015013803A (es) * 2013-03-29 2016-02-16 Merrimack Pharmaceuticals Inc Proteina de fusion de enlace al cartilago.
KR101558498B1 (ko) 2013-04-26 2015-10-12 건국대학교 산학협력단 노년황반변성의 진단, 치료 및 예방용 조성물 및 노년황반변성에 대한 진단 방법
JP6169710B2 (ja) * 2013-09-10 2017-07-26 富士フイルム株式会社 多能性幹細胞の培養方法、培養用キット及び多能性幹細胞培養用培地
WO2016105332A1 (en) * 2014-12-22 2016-06-30 Avon Products, Inc. Peptides and their use in the treatment of skin
US20170304178A1 (en) * 2014-12-23 2017-10-26 Avon Products, Inc. Peptides and Their Use in the Treatment of Skin
WO2016105360A1 (en) * 2014-12-23 2016-06-30 Avon Products, Inc. Peptides and their use in the treatment of skin
AU2016229053B2 (en) * 2015-03-11 2018-07-12 Ap Biosciences, Inc. Fusion protein comprising a ligand binding domain of VEGF and PDGF
WO2019010533A1 (en) * 2017-07-12 2019-01-17 Factor Therapeutics Limited TREATMENT OF OCULAR DISORDERS
WO2023233340A1 (en) * 2022-06-02 2023-12-07 Avant Meats Company Limited Genetically engineered yeast cells, recombinant proteins produced thereof and applications thereof

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US592904A (en) 1897-11-02 Drill
US4843000A (en) 1979-12-26 1989-06-27 Syntex (U.S.A.) Inc. Simultaneous calibration heterogeneous immunoassay
US4849338A (en) 1982-07-16 1989-07-18 Syntex (U.S.A.) Inc. Simultaneous calibration heterogeneous immunoassay
US4366241A (en) 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
US5091513A (en) 1987-05-21 1992-02-25 Creative Biomolecules, Inc. Biosynthetic antibody binding sites
WO1990000569A1 (en) 1988-07-15 1990-01-25 Central Sydney Area Health Service Acid-labile subunit (als) of insulin-like-growth factor (igf) binding protein complex
US6090790A (en) 1989-12-14 2000-07-18 Eriksson; Elof Gene delivery by microneedle injection
JP2866134B2 (ja) * 1990-02-05 1999-03-08 寳酒造株式会社 機能性ポリペプチド
AU649066B2 (en) 1990-07-25 1994-05-12 Syngene, Inc. Circular extension for generating multiple nucleic acid complements
US6054122A (en) 1990-11-27 2000-04-25 The American National Red Cross Supplemented and unsupplemented tissue sealants, methods of their production and use
JP2829405B2 (ja) * 1991-10-14 1998-11-25 寳酒造株式会社 機能性ポリペプチド
US5958764A (en) 1992-04-30 1999-09-28 Baylor College Of Medicine Specific expression vectors and methods of use
WO1994018232A1 (en) 1993-02-12 1994-08-18 Repligen Corporation Methods for generating broadly neutralizing anti-hiv antibodies and antigens capable of eliciting same
US5422252A (en) 1993-06-04 1995-06-06 Becton, Dickinson And Company Simultaneous amplification of multiple targets
US5962427A (en) 1994-02-18 1999-10-05 The Regent Of The University Of Michigan In vivo gene transfer methods for wound healing
AUPM672594A0 (en) 1994-07-08 1994-08-04 Royal Children's Hospital Research Foundation A method for the prophylaxis and/or treatment of proliferative and/or inflammatory skin disorders
AU714486B2 (en) 1995-11-21 2000-01-06 Yale University Unimolecular segment amplification and detection
US5752019A (en) 1995-12-22 1998-05-12 International Business Machines Corporation System and method for confirmationally-flexible molecular identification
US5835382A (en) 1996-04-26 1998-11-10 The Scripps Research Institute Small molecule mimetics of erythropoietin
US6077987A (en) 1997-09-04 2000-06-20 North Shore-Long Island Jewish Research Institute Genetic engineering of cells to enhance healing and tissue regeneration
AU3192299A (en) 1998-03-18 1999-10-11 Wake Forest University Improved implantable biomaterials, compositions and methods for their preparation and uses thereof
US6436897B2 (en) 1998-06-01 2002-08-20 Celtrix Pharmaceuticals, Inc. Pharmaceutical formulations for IGF/IGFBP
JP2001190280A (ja) * 1999-02-19 2001-07-17 Terumo Corp コラーゲン結合性生理活性ポリペプチド
AU3897200A (en) * 1999-03-18 2000-10-04 Hope Heart Institute, The Endothelial cell stimulation by a complex of fibronectin and vascular endothelial growth factor
JP2002060400A (ja) * 2000-08-17 2002-02-26 Terumo Corp コラーゲン結合活性および血管新生調節活性を有するハイブリッドポリペプチド
AUPR030900A0 (en) * 2000-09-22 2000-10-12 Queensland University Of Technology Growth factor complex

Also Published As

Publication number Publication date
KR101175687B1 (ko) 2012-08-22
JP2007523598A (ja) 2007-08-23
KR20120051747A (ko) 2012-05-22
ES2372388T3 (es) 2012-01-19
JP2011120595A (ja) 2011-06-23
EP2357195B1 (de) 2016-06-29
US7659367B2 (en) 2010-02-09
EP2357195A1 (de) 2011-08-17
EP1594895B1 (de) 2011-08-24
EP2357194A1 (de) 2011-08-17
KR20050103288A (ko) 2005-10-28
EP1594895A4 (de) 2007-05-09
CA2515335A1 (en) 2004-08-19
DK1594895T3 (da) 2011-12-12
WO2004069871A1 (en) 2004-08-19
CN1774448A (zh) 2006-05-17
JP4717799B2 (ja) 2011-07-06
NZ541738A (en) 2006-03-31
CN1774448B (zh) 2012-07-18
US20060194292A1 (en) 2006-08-31
KR101179678B1 (ko) 2012-09-04
AU2003900481A0 (en) 2003-02-20
ZA200506991B (en) 2006-06-28
HK1091216A1 (en) 2007-01-12
EP1594895A1 (de) 2005-11-16
CA2515335C (en) 2013-07-30

Similar Documents

Publication Publication Date Title
HK1091216A1 (en) Growth factor complexes and modulation of cell migration and growth
Bian et al. Hydrogels that mimic developmentally relevant matrix and N-cadherin interactions enhance MSC chondrogenesis
Nikitovic et al. Lumican regulates osteosarcoma cell adhesion by modulating TGFβ2 activity
DE602005026866D1 (de) Vewendung von dreidimensionalem kultiviertem gewebe zur behandlung von kongestivem herzversagen
ATE467425T1 (de) Gezielte zufuhr von pharmazeutischen agenzien zu verletzten geweben
CY1108960T1 (el) Αντισωματα αποκλεισμου cripto και οι χρησεις τους
ATE439369T1 (de) Methode und zubereitung zur hemmung von angiogenese
ATE552849T1 (de) Behandlungsverfahren unter verwendung von ctla-4 antikörpern
BR0315666A (pt) Dna de a34 e a33 do tipo 3, proteìnas, seus anticorpos e métodos de tratamento usando os mesmos
UA90657C2 (ru) Ловушки vegf и их терапевтические применения
MXPA05006043A (es) Polipeptidos terapeuticos, homologos de los mismos, fragmentos de los mismos y para uso al modular la agregacion mediada de plaquetas.
BR112012013035A2 (pt) fibronectina: quimeras do fator do crescimento
DE60130797D1 (de) Verwendung von spezifischen erbb4 antagonisten zur behandlung von stenose
ATE470672T1 (de) Verwendung von cupredoxin-proteine für krebstherapie
BR112012030821A2 (pt) vitronectina:fator de crescimento quimeras queratinócitos
Marmotti et al. Pulsed Electromagnetic Fields Improve Tenogenic Commitment of Umbilical Cord‐Derived Mesenchymal Stem Cells: A Potential Strategy for Tendon Repair—An In Vitro Study
NO971341D0 (no) Promoter for reseptor tyrosinkinase TIE
Jo et al. Molecular regulators of cellular mechanoadaptation at cell–material interfaces
DE60133104D1 (de) Verfahren und zusammensetzungen zur behandlung von neoplastischen erkrankungen mittels chemotherapie und strahlungssensibilisatoren
ATE386050T1 (de) Peptide, die die heparinbindungsdomäne von vegf und vegfr-2 binden
DE60042793D1 (de) Inhibitor des hepatozytwachstumsfaktoraktivators und dessen verwendung zur modulation von angiogenese und herzvaskularisierung
DK1064018T3 (da) Anvendelsen af isolerede domæner af Type IV kollagen til at modificere celle- og vævsinteraktioner
DE60132301D1 (de) Verwendung der extrazellulären Domäne von TRADE Molekülen in Medikamenten zur Behandlung von Neoplasie
ATE349521T1 (de) Mit cd40 und traf interagierende proteine
ATE374048T1 (de) Verwendung von matrixprotein für gesteuerte geweberegenerationen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1594895

Country of ref document: EP